MedTrace Logo

Tomato Supplementation and Cardiovascular Health

NCT03209817 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2018-04-06

No results posted yet for this study

Summary

This clinical trial aims to test the effects of consuming two types of tomato (one ordinary cherry red tomato containing lycopene, and the other a yellow cherry tomato low in lycopene), on cardiovascular risk factors including endothelial function as the primary outcome, and blood lipids, inflammatory factors and blood pressure.

In a crossover design, participants of this study will randomly consume 300g of raw cherry (red and yellow) tomatoes per day for four weeks, with a control period consuming no tomato products. Before and after each intervention, the cardiovascular outcomes mentioned above will be measured in the clinic.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Red cherry tomato

300 grams of cherry tomatoes per day for four weeks (each)

DIETARY_SUPPLEMENT

Yellow cherry tomato

300 grams of cherry tomatoes per day for four weeks (each)

Sponsors & Collaborators

  • Northumbria University

    lead OTHER

Principal Investigators

  • Jose Lara, PhD · Northumbria University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-23
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03209817 on ClinicalTrials.gov